NCT00236938View on ClinicalTrials.gov

Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

September 30, 2004

Study Completion Date

October 31, 2004

Conditions
Anemia
Interventions
DRUG

Venofer and stable erythropoietin (EPO) regimen

Fixed dose of erythropoietin (EPO) and Venofer (300mg) administered intravenous infusion over 1.5 hours on Days 1 and 15, and Venofer (400mg) administered intravenous infusion over 2.5 hours on Day 29.

DRUG

stable erythropoietin (EPO) regimen

Stable erythropoietin (EPO) dose and no supplemental iron.

Sponsors
All Listed Sponsors
lead

American Regent, Inc.

INDUSTRY

NCT00236938 - Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis | Biotech Hunter | Biotech Hunter